284 related articles for article (PubMed ID: 16222197)
1. Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study.
Kennedy DW; Kuhn FA; Hamilos DL; Zinreich SJ; Butler D; Warsi G; Pfister PJ; Tavakkol A
Laryngoscope; 2005 Oct; 115(10):1793-9. PubMed ID: 16222197
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study.
Liang KL; Su MC; Shiao JY; Tseng HC; Hsin CH; Lin JF; Jiang RS
Am J Rhinol; 2008; 22(1):52-8. PubMed ID: 18284860
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial.
Ponikau JU; Sherris DA; Weaver A; Kita H
J Allergy Clin Immunol; 2005 Jan; 115(1):125-31. PubMed ID: 15637558
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
[TBL] [Abstract][Full Text] [Related]
5. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study.
Videler WJ; van Drunen CM; Reitsma JB; Fokkens WJ
Rhinology; 2008 Jun; 46(2):92-8. PubMed ID: 18575008
[TBL] [Abstract][Full Text] [Related]
6. Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis.
Weschta M; Rimek D; Formanek M; Podbielski A; Riechelmann H
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):743-7. PubMed ID: 16847182
[TBL] [Abstract][Full Text] [Related]
7. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial.
Weschta M; Rimek D; Formanek M; Polzehl D; Podbielski A; Riechelmann H
J Allergy Clin Immunol; 2004 Jun; 113(6):1122-8. PubMed ID: 15208594
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis.
Ebbens FA; Scadding GK; Badia L; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Dijkgraaf MG; Lund V; Fokkens WJ
J Allergy Clin Immunol; 2006 Nov; 118(5):1149-56. PubMed ID: 17088142
[TBL] [Abstract][Full Text] [Related]
9. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
[TBL] [Abstract][Full Text] [Related]
10. Nasal amphotericin irrigation in chronic rhinosinusitis.
Stankiewicz JA; Musgrave BK; Scianna JM
Curr Opin Otolaryngol Head Neck Surg; 2008 Feb; 16(1):44-6. PubMed ID: 18197021
[TBL] [Abstract][Full Text] [Related]
11. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery.
Aukema AA; Mulder PG; Fokkens WJ
J Allergy Clin Immunol; 2005 May; 115(5):1017-23. PubMed ID: 15867860
[TBL] [Abstract][Full Text] [Related]
12. Systemic corticosteroids for allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal polyposis: a comparative study.
Landsberg R; Segev Y; DeRowe A; Landau T; Khafif A; Fliss DM
Otolaryngol Head Neck Surg; 2007 Feb; 136(2):252-7. PubMed ID: 17275549
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
14. Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis.
Giger R; Pasche P; Cheseaux C; Cantini L; Rossetti A; Landis BN; Lacroix JS
Eur Arch Otorhinolaryngol; 2003 Mar; 260(3):135-40. PubMed ID: 12687385
[TBL] [Abstract][Full Text] [Related]
15. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Marple BF; Roberts CS; de Caprariis PJ; Reisman A
Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
[TBL] [Abstract][Full Text] [Related]
16. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.
Ebbens FA; Georgalas C; Luiten S; van Drunen CM; Badia L; Scadding GK; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Lund VJ; Fokkens WJ
Laryngoscope; 2009 Feb; 119(2):401-8. PubMed ID: 19160404
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis.
Wallwork B; Coman W; Mackay-Sim A; Greiff L; Cervin A
Laryngoscope; 2006 Feb; 116(2):189-93. PubMed ID: 16467702
[TBL] [Abstract][Full Text] [Related]
18. Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis.
Hadley JA; Mösges R; Desrosiers M; Haverstock D; van Veenhuyzen D; Herman-Gnjidic Z
Laryngoscope; 2010 May; 120(5):1057-62. PubMed ID: 20422704
[TBL] [Abstract][Full Text] [Related]
19. Safe coadministration of terbinafine and terfenadine: a placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteers.
Robbins B; Chang CT; Cramer JA; Garreffa S; Hafkin B; Hunt TL; Meligeni J
Clin Pharmacol Ther; 1996 Mar; 59(3):275-83. PubMed ID: 8653990
[TBL] [Abstract][Full Text] [Related]
20. The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo.
Inanli S; Oztürk O; Korkmaz M; Tutkun A; Batman C
Laryngoscope; 2002 Feb; 112(2):320-5. PubMed ID: 11889391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
